BNP Paribas Financial Markets
LYRA

BNP Paribas Financial Markets’s LYRA THERAPEUTICS INC LYRA Stock Holding History

BNP Paribas Financial Markets’s Portfolio LYRA Stock Details LYRA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-16
Closed -$49 – 5991
2025
Q4 		$49 Hold
16
– – ﹤0.01% 5647
2025
Q3 		$104 Sell
16
-9
-36% -$66 ﹤0.01% 5433
2025
Q2 		$224 Sell
25
-4,826
-99% -$40K ﹤0.01% 5279
2025
Q1 		$30.6K Sell
4,851
-47
-1% -$440 ﹤0.01% 4429
2024
Q4 		$50.6K Buy
+4,898
New +$53.9K ﹤0.01% 4426
2022
Q4 		– Sell
-1
Closed -$150 – 4363
2022
Q3 		$150 Buy
+1
New +$296 ﹤0.01% 4629

Other funds holding LYRA

SM
Sabby Management Miami Beach, Florida $45.1M AUM 74.25% 1-Year Est. Return

BNP Paribas Financial Markets's LYRA Position: Q1 2026 in Review

BNP Paribas Financial Markets sold out of LYRA THERAPEUTICS INC (LYRA) in Q1 2026, closing a stake of 16 shares — an estimated $49 sold.

BNP Paribas Financial Markets first reported a position in LYRA in Q3 2022 and held it in 6 quarters. The position peaked at $50.6K in Q4 2024. 1 fund tracked by Wall St. Rank holds LYRA as of Q1 2026.

  • BNP Paribas Financial Markets reported no remaining LYRA THERAPEUTICS INC position as of Q1 2026 after selling out during the quarter.
  • BNP Paribas Financial Markets sold 16 LYRA THERAPEUTICS INC shares in Q1 2026, an estimated $49.
  • BNP Paribas Financial Markets first reported a position in LYRA THERAPEUTICS INC in Q3 2022 and held it in 6 quarters.
  • BNP Paribas Financial Markets's LYRA THERAPEUTICS INC position peaked at $50.6K in Q4 2024.
  • 1 fund tracked by Wall St. Rank held LYRA THERAPEUTICS INC as of Q1 2026.

Based on BNP Paribas Financial Markets's 13F filing for Q1 2026, filed 12 May 2026.